Heikki Minn - UTU Research Portal

Heikki Minn

- ,
Department of Clinical Medicine (Faculty of Medicine)
- Docent,
Faculty of Medicine (University of Turku)

heikki.minn@utu.fi

: https://orcid.org/0000-0002-5878-4333

5 of 8

Diffusion weighted imaging of prostate cancer xenografts: comparison of bayesian modeling and independent least squares fitting (2016)
- International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition. Proceedings
Parisa Movahedi, Hanne Hakkarainen, Harri Merisaari, Heidi Liljenbäck, Helena Virtanen, Hannu Juhani Aronen, Heikki Minn, Matti Poutanen, Anne Roivainen, Timo Liimatainen, Ivan Jambor
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial (2016)
- Acta Oncologica
Ivan Jambor, Anna Kuisma, Susan Ramadan, Riikka Huovinen, Minna Sandell, Sami Kajander, Jukka Kemppainen, Esa Kauppila, Joakim Auren, Harri Merisaari, Jani Saunavaara, Tommi Noponen, Heikki Minn, Hannu J. Aronen, Marko Seppänen
Radiotherapy volume delineation using dynamic [18F]-FDG PET/CT imaging in patients with oropharyngeal cancer: a pilot study (2016)
- International journal of computer assisted radiology and surgeryLääkärilehti
Silvoniemi A, Din MU, Suilamo S, Shepherd T, Minn H
Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction2016
- Magnetic Resonance in Medicine
Jambor I, Pesola M, Taimen P, Merisaari H, Boström PJ, Minn H, Liimatainen T, Aronen HJ
Syöpäpotilaiden hoitoonpääsyn pullonkaulatEvaluation of different mathematical models for diffusion-weighted imaging of normal prostate and prostate cancer using high b-values: A repeatability study (2016)
- Lääkärilehti
Minn Heikki, Irjala Heikki, Vallius Tuulia, Haavisto Lotta, Lempiäinen Salla, Jyrkkiö Sirkku
Syöpätautien hoitokäytännöt ja resursointi yliopistosairaaloissa vertaiskehittämisen avulla arvioituna (2016)
Leskelä Riikka-Leena, Silander Katariina, Pennanen Paula, Turpeenniemi-Hujanen Taina, Klintrup Katariina, Lehtinen Tuula, Kellokumpu-Lehtinen Pirkko-Liisa, Minn Heikki, Tyynelä-Korhonen Kristiina, Kolhonen Vuokko, Saarto Tiina, Mattson Johanna, Bono Petri
Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma (2016)
- Acta Oncologica
Koskivuo I, Kemppainen J, Giordano S, Seppänen M, Veräjänkorva E, Vihinen P, Minn H
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial (2015)
- Lancet Oncology
Mesia R, Henke M, Fortin A, Minn H, Ancona ACY, Cmelak A, Markowitz AB, Hotte SJ, Singh S, Chan ATC, Merlano MC, Skladowski K, Zhang A, Oliner KS, VanderWalde A, Giralt J
(2015)
- Magnetic Resonance in MedicineJournal of Neuro-Oncology
Jambor Ivan, Merisaari Harri, Taimen Pekka, Boström Peter, Minn Heikki, Pesola Marko, Aronen Hannu Juhani
(2015)
- DuodecimEJNMMI Research
Grénman R, Koivunen P, Minn H
Oncologic Patients' Knowledge Expectations and Cognitive Capacities During Illness Trajectory: Analysis of Critical Moments and Factors (2015)
- Holistic Nursing PracticeEJNMMI Research
Heli Vaartio-Rajalin, Helena Leino-Kilpi, Liisa Iire, Kimmo Lehtonen, Heikki Minn
(2015)
- Nursing ResearchActa Oncologica
Vaartio-Rajalin H, Huumonen T, Iire L, Jekunen A, Leino-Kilpi H, Minn H, Paloniemi J
(2015)
- Journal of Magnetic Resonance Imaging
Ivan Jambor, Esa Kähkönen, Pekka Taimen, Harri Merisaari, Jani Saunavaara, Kalle Alanen, Branislav Obsitnik, Heikki Minn, Viera Lehotska, Hannu J. Aronen
Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival (2015)
Kiviniemi A, Gardberg M, Frantzen J, Parkkola R, Vuorinen V, Pesola M, Minn H
Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with Ga-68-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy (2015)
Aida Kiviniemi, Maria Gardberg, Janek Frantzén, Marko Pesola, Ville Vuorinen, Riitta Parkkola, Tuula Tolvanen, Sami Suilamo, Jarkko Johansson, Pauliina Luoto, Jukka Kemppainen, Anne Roivainen, Heikki Minn
18F-Fluorodihydroxyphenylalanine (FDOPA) in the Diagnosis of NET (2014)
- PET Clinics
PET Clinics Minn H, Kemppainen J, Kauhanen S, Forsback S, Seppänen M
Evaluation of repeated [18F]EF5 PET/CT scans and tumor growth rate in experimental head and neck carcinomas (2014)
Silvoniemi Antti, Silén Jonna, Forsback Sarita, Löyttyniemi Eliisa, Schrey Aleksi R, Solin Olof, Grénman Reidar, Minn Heikki, Grönroos Tove J
Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies. (2014)
Kiviniemi A, Gardberg M, Autio A, Li XG, Heuser VD, Liljenbäck H, Käkelä M, Sipilä H, Kurkipuro J, Ylä-Herttuala S, Knuuti J, Minn H, Roivainen A.
Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET (2014)
- BMC Cancer
Grönroos TJ, Lehtiö K, Söderström KO, Kronqvist P, Laine J, Eskola O, Viljanen T, Grénman R, Solin O, Minn H
Hypoxia imaging for radiotherapy planning (2014) Therapeutic Nuclear Medicine Minn H, Seppälä J, Shepherd T